FTC Signs Off On Grifols-Talecris Deal Divestitures
The Federal Trade Commission signed off Wednesday on Grifols SA's antitrust-related divestitures of two plasma collection centers and a blood fractionation facility as part of its $3.4 billion purchase of rival...To view the full article, register now.
Already a subscriber? Click here to view full article